SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread

Zim shareholders approve $4.2 billion sale to Hapag-Lloyd

Iron Beam and Iron Dome at the frontlines of a quiet Israel-UAE alliance

Unframe CEO: "I foresaw that enterprises were going to struggle to adopt AI"

Buzz

Most popular

Daily

Weekly

1

From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector

2

The 50 most promising Israeli startups - 2026

3

SAP taps Israeli executive to lead global AI push

4

Indian Embassy cancels $42 million Tel Aviv office deal at last minute

5

“We’re not chasing large acquisitions”: Check Point falls to two-year low as CEO eyes ‘game-changing’ tech

Pharmaceuricals

3 stories about Pharmaceuricals

Closure of another criminal case will help Teva's new CEO to focus on return to growth

22.08.23|Sophie Shulman

The pharmaceutical company has reached a compromise after being suspected of price-fixing with other generic drug manufacturers in the US. In the first four years, it will pay $22.5 million and in 2028 - $135 million. In addition, the company will donate two drugs worth $50 million to humanitarian organizations

ריצ'רד פרנסיס מנכ"ל טבע החדש על רקע אתר חברת טבע בכפר סבא

Schultz kept Teva away from the abyss, but couldn't find a runway to growth

22.11.22|Sophie Shulman

Kare Schultz, who served as CEO of the pharmaceutical company for the past five years, has left the company a year early after amassing a salary of more than $100 million. His replacement, Richard Francis, is taking over with less debt and less legal issues, but with the big challenge of creating new growth engines

United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal

30.04.18|Amarelle Wenkert

In 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics